Breaking News Instant updates and real-time market news.

ABEO

Abeona Therapeutics

$8.90

-0.4 (-4.30%)

08:12
07/18/17
07/18
08:12
07/18/17
08:12

Abeona Therapeutics receives guidance from FDA to commence EB-101 Phase 3 trial

Abeona Therapeutics announced guidance from a recent Type-C meeting with the FDA which has recommended accelerating the EB-101 program into a pivotal Phase 3 trial. The company continues to engage the FDA on the final Phase 3 clinical trial design, planned to commence early 2018, and will provide an update on the program in the coming months. "The FDA guidance is an important milestone in our clinical development plan for EB-101, and we are pleased to be moving forward into a registrational Phase 3 clinical study in 2018. Abeona is committed to advancing innovative gene therapies that address the unmet needs of patients suffering with dystrophic epidermolysis bullosa, a devastating rare skin disease. We are grateful that the FDA has recognized EB-101 as a rare disease product that addresses the underlying disease pathology to offer significant therapeutic benefit for RDEB patients, and we look forward to the collective work ahead in advancing this therapy," stated Timothy J. Miller, Ph.D., President and CEO of Abeona. Abeona's EB-101 product is an autologous, ex-vivo gene therapy in which the COL7A1 gene is inserted into a patient's own skin cells for the treatment of the underlying disease in Recessive Dystrophic Epidermolysis Bullosa. The EB-101 program has been granted Orphan Drug and Rare Pediatric Disease Designations from the FDA and Orphan Drug Designation from the European Medicines Agency.

ABEO Abeona Therapeutics
$8.90

-0.4 (-4.30%)

03/06/17
FBRC
03/06/17
NO CHANGE
FBRC
FBR sees 'prime' merger environment for biotechs under Trump
Potential tax reform and FDA policy changes under President Trump could "prime the pump" for acquisitions of clinical-stage biotech companies by Big Pharma, FBR Capital analysts led by Chris Meekins tell investors in a research note. These police moves, coupled with the repeal of some taxes associated with the Affordable Care Act, are likely to increase funds for companies looking to make acquisitions, the analysts contend. Within its coverage universe, FBR sees TESARO (TSRO), Agile Therapeutics (AGRX), Kite Pharma (KITE), Juno Therapeutics (JUNO), Acceleron Pharma (XLRN), Abeona Therapeutics (ABEO), Aurinia Pharmaceuticals (AUPH), Geron (GERN) and Genocea Biosciences (GNCA) as "primary targets for those looking to make acquisitions."
01/06/17
JEFF
01/06/17
INITIATION
Target $11
JEFF
Buy
Abeona Therapeutics initiated with a Buy at Jefferies
Jefferies analyst Gena Wang started Abeona Therapeutics with a Buy rating and $11 price target. The analyst sees a favorable risk/reward ahead of data readouts in the first half of 2017.
12/12/16
CANT
12/12/16
NO CHANGE
Target $21
CANT
Abeona short report 'factually incorrect and misleading,' says Cantor
Cantor Fitzgerald analyst Elemer Piros said the short report published on Seeking Alpha regarding Abeona Therapeutics is "factually incorrect and misleading." Abeona infuses its drug to the bloodstream, unlike Lysogene, whose failed clinical trial was conducted with a gene therapy that was directly injected into a handful of brain regions, Piros points out. Abeona also employs an AAV9 vector, which "delivers and promotes expression" in both neurons and glial cells, according to Piros, who reiterates his Buy rating and $21 price target on Abeona shares.
09/29/16
MAXM
09/29/16
NO CHANGE
Target $14
MAXM
Buy
Abeona Therapeutics price target raised to $14 from $8 at Maxim
Maxim analyst Jason McCarthy raised Abeona's price target to $14 from $8 saying he expects multiple data points across several gene therapy programs to potentially push shares higher. The analyst said clinical development is underway in Abeona's Sanfilippo with positive data in two patients so far, and data from more patients are expected this fall. The company is also advancing a second Sanfilippo gene therapy, ABO-101, into the clinic later this year. Also, Abeona has brought on board a more advanced gene therapy from Stanford University, EB-101, to treat a rare skin disease which demonstrated positive data in five patients and has advanced to phase II, McCarthy wrote.

TODAY'S FREE FLY STORIES

03:35
07/27/17
07/27
03:35
07/27/17
03:35
General news
FX Action: USD-CAD has traded yet lower »

FX Action: USD-CAD has…

02:25
07/27/17
07/27
02:25
07/27/17
02:25
General news
FX Update: The Fed's statement has put the dollar under the cosh »

FX Update: The…

01:30
07/27/17
07/27
01:30
07/27/17
01:30
General news
FX Action: USD-JPY logged a low at 110.78 »

FX Action: USD-JPY logged…

RETA

Reata Pharmaceuticals

$32.06

-0.46 (-1.41%)

22:11
07/26/17
07/26
22:11
07/26/17
22:11
Syndicate
Reata Pharmaceuticals 3.25M share Secondary priced at $31.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Jul

SNNA

Sienna Biopharmaceuticals

22:03
07/26/17
07/26
22:03
07/26/17
22:03
Syndicate
Sienna Biopharmaceuticals 4.3M share IPO priced at $15.00 »

The deal priced between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PG

Procter & Gamble

$89.30

0.16 (0.18%)

, BUD

AB InBev

$115.71

1.75 (1.54%)

20:25
07/26/17
07/26
20:25
07/26/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$89.30

0.16 (0.18%)

BUD

AB InBev

$115.71

1.75 (1.54%)

CMCSA

Comcast

$39.35

-0.4 (-1.01%)

CMCSK

Comcast

VZ

Verizon

$44.40

0.42 (0.95%)

MO

Altria Group

$71.73

-0.51 (-0.71%)

CELG

Celgene

$137.75

1.31 (0.96%)

CHTR

Charter

$348.77

0.77 (0.22%)

UPS

UPS

$112.29

-0.93 (-0.82%)

BMY

Bristol-Myers

$55.98

0.03 (0.05%)

DOW

Dow Chemical

$66.42

-0.43 (-0.64%)

COP

ConocoPhillips

$43.70

0.05 (0.11%)

RTN

Raytheon

$168.88

-0.71 (-0.42%)

ADP

ADP

$105.98

2.8 (2.71%)

JCI

Johnson Controls

$43.32

-0.86 (-1.95%)

LUV

Southwest

$59.52

0.7 (1.19%)

MCK

McKesson

$166.35

-1.28 (-0.76%)

PCG

PG&E

$67.90

0.39 (0.58%)

VLO

Valero

$67.99

-0.45 (-0.66%)

ALXN

Alexion

$131.07

1.72 (1.33%)

ZBH

Zimmer Biomet

$128.70

-0.07 (-0.05%)

MGM

MGM Resorts

$33.87

-0.4 (-1.17%)

DPS

Dr Pepper Snapple

$92.15

0.26 (0.28%)

KKR

KKR

$19.31

-0.15 (-0.77%)

TWTR

Twitter

$19.61

-0.36 (-1.80%)

LLL

L3 Technologies

$175.52

-1.79 (-1.01%)

NLSN

Nielsen

$39.89

1.27 (3.29%)

DNKN

Dunkin' Brands

$52.52

-0.71 (-1.33%)

WIX

Wix.com

$76.85

0.9 (1.19%)

TREE

LendingTree

$183.80

-2.25 (-1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 07

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 10

    Aug

  • 14

    Aug

  • 21

    Aug

  • 29

    Aug

  • 30

    Aug

  • 11

    Sep

  • 13

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 23

    Oct

  • 09

    Nov

  • 05

    Mar

DISCA

Discovery

$26.58

0.65 (2.51%)

, SNI

Scripps Networks

$84.07

2.62 (3.22%)

19:33
07/26/17
07/26
19:33
07/26/17
19:33
Periodicals
Discovery in lead to buy Scripps, Reuters says »

Discovery (DISCA) has…

DISCA

Discovery

$26.58

0.65 (2.51%)

SNI

Scripps Networks

$84.07

2.62 (3.22%)

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 09

    Aug

VIA

Viacom

$39.75

-0.6 (-1.49%)

, VIAB

Viacom

$34.37

-0.64 (-1.83%)

19:30
07/26/17
07/26
19:30
07/26/17
19:30
Periodicals
Breaking Periodicals news story on Viacom, Viacom »

Viacom drops bidding for…

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

DISCA

Discovery

$26.58

0.65 (2.51%)

, SNI

Scripps Networks

$84.07

2.62 (3.22%)

19:28
07/26/17
07/26
19:28
07/26/17
19:28
Periodicals
Discovery offer for Scripps deemed superior to Viacom's, CNBC's Faber says »

Scripps (SNI) will enter…

DISCA

Discovery

$26.58

0.65 (2.51%)

SNI

Scripps Networks

$84.07

2.62 (3.22%)

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 09

    Aug

CRAY

Cray

$18.60

-0.3 (-1.59%)

, STX

Seagate

$32.34

-0.86 (-2.59%)

19:18
07/26/17
07/26
19:18
07/26/17
19:18
Hot Stocks
Cray, Seagate enter partnership centered around ClusterStor »

Cray (CRAY) announced it…

CRAY

Cray

$18.60

-0.3 (-1.59%)

STX

Seagate

$32.34

-0.86 (-2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:18
07/26/17
07/26
19:18
07/26/17
19:18
Earnings
MiMedx backs FY17 adjusted EPS view of 31c-33c, consensus 30c »

Raises FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:17
07/26/17
07/26
19:17
07/26/17
19:17
Earnings
Breaking Earnings news story on MiMedx »

MiMedx sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:16
07/26/17
07/26
19:16
07/26/17
19:16
Earnings
MiMedx reports Q2 EPS 7c, consensus 7c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

GE

General Electric

$25.59

0.15 (0.59%)

, AEP

American Electric

$69.45

0.61 (0.89%)

19:08
07/26/17
07/26
19:08
07/26/17
19:08
Hot Stocks
Invenergy, GE to build 2,000 megawatt wind farm in Oklahoma »

Invenergy, along with GE…

GE

General Electric

$25.59

0.15 (0.59%)

AEP

American Electric

$69.45

0.61 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 02

    Oct

PSA

Public Storage

$210.06

2.34 (1.13%)

19:05
07/26/17
07/26
19:05
07/26/17
19:05
Earnings
Pure Storage reports Q2 core FFO $2.51, consensus $2.54 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BRK.A

Berkshire Hathaway

$259,600.00

189.98 (0.07%)

, BRK.B

Berkshire Hathaway

$173.02

0.08 (0.05%)

18:57
07/26/17
07/26
18:57
07/26/17
18:57
Periodicals
Breaking Periodicals news story on Berkshire Hathaway, Berkshire Hathaway »

Elliott wins short delay…

BRK.A

Berkshire Hathaway

$259,600.00

189.98 (0.07%)

BRK.B

Berkshire Hathaway

$173.02

0.08 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTI

AXT, Inc.

$7.60

0.25 (3.40%)

18:43
07/26/17
07/26
18:43
07/26/17
18:43
Earnings
AXT, Inc. sees Q3 EPS 8c-10c, consensus 7c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 03

    Aug

  • 10

    Aug

  • 19

    Sep

NGD

New Gold

$3.17

0.15 (4.97%)

18:42
07/26/17
07/26
18:42
07/26/17
18:42
Hot Stocks
New Gold names Paula Myson as CFO »

Myson has over 25 years…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

NGD

New Gold

$3.17

0.15 (4.97%)

18:40
07/26/17
07/26
18:40
07/26/17
18:40
Earnings
New Gold reports Q2 adjusted EPS 2c, consensus 2c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PKG

Packaging Corp.

$108.80

0.22 (0.20%)

18:37
07/26/17
07/26
18:37
07/26/17
18:37
Earnings
Packaging Corp. sees Q3 EPS $1.68, consensus $1.66 »

Looking ahead to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 12

    Sep

PKG

Packaging Corp.

$108.80

0.22 (0.20%)

18:36
07/26/17
07/26
18:36
07/26/17
18:36
Earnings
Packaging Corp. reports Q2 adjusted EPS $1.52, consensus $1.47 »

Reports Q2 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 12

    Sep

CUBI

Customers Bancorp

$28.24

-0.25 (-0.88%)

18:31
07/26/17
07/26
18:31
07/26/17
18:31
Hot Stocks
Customers Bank expands private, commercial banking unit into Chicago »

Customers Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

HNHPF

Hon Hai Precision

$7.70

-0.02 (-0.26%)

18:21
07/26/17
07/26
18:21
07/26/17
18:21
Hot Stocks
White House welcomes Foxconn announcement of LCD panel plant in Wisconsin »

President Donald J. Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFBK

Northfield Bancorp

$16.69

-0.34 (-2.00%)

18:15
07/26/17
07/26
18:15
07/26/17
18:15
Earnings
Northfield Bancorp reports Q2 EPS 18c, consensus 16c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TXN

Texas Instruments

$82.53

1.14 (1.40%)

18:10
07/26/17
07/26
18:10
07/26/17
18:10
Periodicals
Texas Instruments' strong results, outlook signal further upside, Barron's says »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.